Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
HLA-E–restricted HIV-1–specific CD8+ T cell responses in natural infection
Anju Bansal, … , June Kan-Mitchell, Paul A. Goepfert
Anju Bansal, … , June Kan-Mitchell, Paul A. Goepfert
Published July 6, 2021
Citation Information: J Clin Invest. 2021;131(16):e148979. https://doi.org/10.1172/JCI148979.
View: Text | PDF
Research Article Infectious disease

HLA-E–restricted HIV-1–specific CD8+ T cell responses in natural infection

  • Text
  • PDF
Abstract

CD8+ T cell responses restricted by MHC-E, a nonclassical MHC molecule, have been associated with protection in an SIV/rhesus macaque model. The biological relevance of HLA-E–restricted CD8+ T cell responses in HIV infection, however, remains unknown. In this study, CD8+ T cells responding to HIV-1 Gag peptides presented by HLA-E were analyzed. Using in vitro assays, we observed HLA-E–restricted T cell responses to what we believe to be a newly identified subdominant Gag-KL9 as well as a well-described immunodominant Gag-KF11 epitope in T cell lines derived from chronically HIV-infected patients and also primed from healthy donors. Blocking of the HLA-E/KF11 binding by the B7 signal peptide resulted in decreased CD8+ T cell responses. KF11 presented via HLA-E in HIV-infected cells was recognized by antigen-specific CD8+ T cells. Importantly, bulk CD8+ T cells obtained from HIV-infected individuals recognized infected cells via HLA-E presentation. Ex vivo analyses at the epitope level showed a higher responder frequency of HLA-E–restricted responses to KF11 compared with KL9. Taken together, our findings of HLA-E–restricted HIV-specific immune responses offer intriguing and possibly paradigm-shifting insights into factors that contribute to the immunodominance of CD8+ T cell responses in HIV infection.

Authors

Anju Bansal, Mika N. Gehre, Kai Qin, Sarah Sterrett, Ayub Ali, Ying Dang, Sojan Abraham, Margaret C. Costanzo, Leon A. Venegas, Jianming Tang, N. Manjunath, Mark A. Brockman, Otto O. Yang, June Kan-Mitchell, Paul A. Goepfert

×

Figure 8

In vitro priming and functional characterization of HLA-E*01–restricted KF11- and KL9-specific CD8+ T cells obtained from 2 HIV-seronegative donors.

Options: View larger image (or click on image) Download as PowerPoint
In vitro priming and functional characterization of HLA-E*01–restricted ...
(A) KF11-specific polyfunctional responses of CD8+ T cell lines from 2 donors that are restricted by both HLA-Ia (221.B*57:01) and HLA-Ib (221.AEH) allomorphs. (B) HLA-A*02:01–restricted (C1R-A*02 used as APCs) and HLA-E–restricted (221.AEH used as APCs) KL9-specific degranulation and IFN-γ production by A*02:01-restricted KL9-specific CD8+ T cell clones (A2.KL9.1 and A2.KL9.4.) from different donors. (C) KL9-specific lysis of cognate peptide–pulsed (10 μg/mL) C1R.A2 and 221.AEH target cells by A2.KL9.1 T cells as determined by the chromium release assay. Error bars represent mean ± SEM. (D) Upregulation of surface CD107a/b expression and intracellular IFN-γ production in the A*02-restricted KL9-specific CD8+ T cells after stimulation by peptide-pulsed 221ΔE, 221ΔE.E*01, 221ΔE.E*03, or 221ΔE.A2 APCs. No response or low-level responses were observed with the no-peptide-pulse negative control.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts